Short answer · Medically reviewed summary · Last updated: 2023-07-13
PEPCK Deficiency is a rare genetic disorder that affects the body's ability to produce an enzyme called phosphoenolpyruvate carboxykinase (PEPCK). This enzyme plays a crucial role in the process of gluconeogenesis, which is the production of glucose from non-carbohydrate sources. PEPCK Deficiency is inherited in an autosomal recessive manner, which means that both parents must carry a copy of the mutated gene for their child to be affected.
PEPCK Deficiency is a rare genetic disorder that affects the body's ability to produce an enzyme called phosphoenolpyruvate carboxykinase (PEPCK). This enzyme plays a crucial role in the process of gluconeogenesis, which is the production of glucose from non-carbohydrate sources.
PEPCK Deficiency is inherited in an autosomal recessive manner, which means that both parents must carry a copy of the mutated gene for their child to be affected. When both parents are carriers, there is a 25% chance with each pregnancy that the child will inherit two copies of the mutated gene and develop PEPCK Deficiency.
Individuals with PEPCK Deficiency typically experience symptoms such as severe hypoglycemia (low blood sugar), lactic acidosis, and failure to thrive. These symptoms can be life-threatening and require immediate medical attention.
Genetic testing can be performed to diagnose PEPCK Deficiency, and prenatal testing is available for families with a known history of the condition. While there is currently no cure for PEPCK Deficiency, treatment focuses on managing symptoms and preventing complications. This may involve a combination of dietary interventions, medications, and close monitoring of blood glucose levels.
It is important for individuals with PEPCK Deficiency and their families to work closely with healthcare professionals who specialize in metabolic disorders. Ongoing research is being conducted to better understand the condition and develop potential therapies.